ProCE Banner Events


2024 Psychiatry Update for APPs

Register now for our Psychiatry Update 2024: NP/PA series, which includes 7 dates in the spring and fall! This free program is offered in a virtual format with up to 5 CE credits.

Join fellow healthcare professionals from around the nation for this popular series, now in its third year! This series covers topics similar to our long-standing Psychiatry Update series with a very practical curriculum to manage these illnesses, with a target audience specifically of NPs and PAs. Register now to secure your seat!

Registered Nurses: 5.00 Nursing contact hours, including 5.00 hours of pharmacotherapy credit

Physician Assistants/Physician Associates: 5.00 AAPA Category 1 CME credits

Who Should Attend

This activity is intended for physician associates and nurse practitioners engaged in the care of patients with psychiatric illness.

Time and location

Friday, July 19, 2024

9:00 AM - 3:30 PM Eastern Time (ET)


Michael Asbach, DMSc, PA-C

Associate Director, International Psychiatry
DENT Neurologic Institute
Buffalo, New York

Jeremy A. Schreiber, MSN, APRN, PMHNP-BC

Adjunct Faculty
Department of Health Sciences
West Liberty University
West Liberty, West Virginia

Chin Hwa (Gina) Dahlem, PhD, FNP-C, FAANP

Clinical Associate Professor 
School of Nursing 
University of Michigan 
Nurse Practitioner 
Ann Arbor, Michigan 

Chelsie Monroe, MSN, APN, PMHNP-BC

Founder, Balanced Mental Wellness
Adjunct Clinical Faculty
University of Colorado Anschutz
College of Nursing
Aurora, Colorado


9:00 AM - 10:05 AM Silent Struggles: Bridging Gaps in PTSD Care for a Holistic Healing Journey and Opening Remarks—presented by Chelsie Monroe, MSN, APN, PMHNP-BC 

  • Explore the frontiers of PTSD care in this session, which will shine a spotlight on the existing gaps in current PTSD treatment modalities, providing a critical examination of where the gaps lie and their impact on individuals. Delve into the promising realm of emerging management strategies as we discuss innovative approaches that hold the potential to reshape and enhance PTSD care.

10:10 AM - 11:10 AM Charting Paths: Evidence-Based Decisions in MDD Treatment Beyond the First Line—presented by Michael Asbach, DMSc, PA-C, Psych-CAQ

  • When a patient with MDD does not respond to a first-line agent, it can be difficult to decide whether to switch or augment therapy. This session will cover the evidence for switching and augmenting treatment and include an overview of the evidence for augmentation agents in the treatment of MDD, reinforced through patient cases.

5-minute break

11:15 AM - 12:15 PM Casting a Wide Net: Identifying and Treating Tardive Dyskinesia in Diverse Patient Populations—presented by Jeremy A. Schreiber, MSN, APRN, PMHNP-BC

  • This session will focus on the importance of screening in older patients, with consideration of changes in patient insight across disease states and over time.​

5-minute break

12:20 PM - 1:20 PM Beyond the Baseline: A Comprehensive Approach to Diagnosis and Treatment of Tardive Dyskinesia Non-CME Educational Talk Sponsored by Neurocrine Biosciences, Inc.—presented by Michael Asbach, DMSc, PA-C

  • This program provides an overview of tardive dyskinesia, including its phenomenology, prevalence, risk factors, and impact. Faculty will share the clinical data for an FDA-approved treatment option for adults with tardive dyskinesia. In addition, participants will have the opportunity to examine cases of patients with tardive dyskinesia by observing videos of the patients before and after treatment. This non-CME educational program is sponsored by Neurocrine Biosciences.

5-minute break

1:25 PM - 2:25 PM Restoring Serenity: Evidence-Based Strategies for Managing Agitation in Alzheimer's Disease—presented by Susan Scanland, MSN, CRNP, GNP-BC, CDP 

  • This session will delve into the complex realm of agitation associated with dementia due to Alzheimer’s disease, exploring its causes, impact, and effective management strategies. From unraveling the underlying triggers to discussing compassionate approaches, this session aims to equip healthcare professionals with the knowledge and tools needed to effectively manage the challenges of agitation in Alzheimer’s disease–related dementia. 

5-minute break

2:30 PM - 3:30 PM Overdose Prevention and Harm Reduction Strategies for Advanced Practice Providers and Closing Remarks—presented by Chin Hwa Dahlem, PhD, FNP-C, FAANP

  • Through expert-led discussions on identification and treatment of opioid use disorder, attendees will gain appreciation for and understanding of the biopsychosocial model of opioid use disorder, helping to reinforce clinical strategies that will promote safe, effective, patient-centered care.


Target Audience
This activity is intended for physician associates and nurse practitioners engaged in the care of patients with psychiatric illness.


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 5.0 contact hours, including 5.0 hours of pharmacotherapy credit.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.


Provided by Clinical Care Options, LLC, in partnership with Practicing Clinicians Exchange.

Supported by an educational grant from Neurocrine Biosciences, Inc.

Contact Information

For customer support please click here.

Mailing Address:


Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.